UK Launches Regulatory Sandbox for AI Med Devices
Image credit:
This month has seen the UK’s medical device regulator, Medicines and Healthcare products Regulatory Agency (MHRA) launch AI Airlock – its regulatory “sandbox” for addressing the unique challenges posed by artificial intelligence (AI) as a medical device (AIaMD).
Going live as of 9 May 2024, the UK Government said AI Airlock has been built in response to the influx ofAIaMDs products hitting the UK market, with the sandbox model a recognised platform for helping to address issues relating to health tech regulation.
“We are currently seeing a marked increase in innovative AlaMD products entering the UK market that have the potential to revolutionise the healthcare landscape and provide improved ways to address patient and public needs,” said MHRA Head of Software and AI, Dr Paul Campbell in a statement.
“As a regulator, we must balance appropriate oversight to protect patient safety with the agility needed to respond to the particular challenges presented by these products to ensure we continue to be an enabler for innovation.
“The launch of the AI Airlock will enhance our collective understanding and accelerate solutions to novel regulatory challenges, ultimately improving the experience of patients.”
Up to six AIaMD projects will be selected for selected for the pilot in coming months, to account for various healthcare fields, bespoke product characteristics and device lifecycles.
It is anticipated that findings from this project will go on to influence AIaMD-related regulatory decision-making not only in the UK, but in countries across the world grappling with these emerging challenges.
Check out the MHRA website for further details about AI Airlock.
Further reading
